source
- STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategyMedical mystery at the AHA conference: A Novartis drug lowered a risk marker for cardiovascular disease but did not lower chance of heart attack or stroke.
- Harvard scientist George Church quits AI startup Radical, alleging partner stole his creditGeorge Church, a prominent Harvard researcher known for advising biotech and synthetic biology ventures, has stepped down from his role at the artificial‑intelligence startup Radical. In a public…